Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)

ISBN 10: 0367896346 / ISBN 13: 9780367896348

Edité par Chapman and Hall/CRC, 2021

A propos de cet article

In. N° de réf. du vendeur ria9780367896348_new

Détails bibliographiques

Titre : Methodologies in Biosimilar Product ...

Éditeur : Chapman and Hall/CRC

Date d'édition : 2021

Reliure : Couverture rigide

Etat : New

A propos de ce titre

Synopsis :

Methodologies in Biosimilar Product Development covers the practical and challenging issues that are commonly encountered during the development, review, and approval of a proposed biosimilar product.

À propos de l?auteur:

Sang Joon Lee, Ph.D., is a Senior Executive Vice President at Celltrion, inc. Dr. Lee was previously an assistant Professor at the University of New Mexico School of Medicine, and a Research Associate and Statistical Analyst at The University of Texas, M.D. Anderson Cancer Center. He received the B.S. degree in Statistics from Inha University, the M.S. degree in Statistics from the Seoul National University, and the Ph.D. degree in Statistics from Texas A&M University. Dr. Lee has authored or co-authored over 100 research papers and invited papers.

Shein-Chung Chow, Ph.D., is a Professor at Duke University School of Medicine. Dr. Chow was previously the Associate Director at the Office of Biostatistics, Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA). Dr. Chow has also held various positions in the pharmaceutical industry such as Vice President at Millennium, Executive Director at Covance, and Director and Department Head at Bristol-Myers Squibb. He received the B.S. degree in mathematics from East China Normal University, and the Ph.D. degree in Statistics from the University of Wisconsin-Madison. Dr. Chow has authored or co-authored over 310 methodology papers and 31 books.